ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Business

Panacea Biotec up 13 pct on US FDA nod for migraine drug

New Delhi [India], Jan 18 (ANI): Shares of Panacea Biotec zoomed over 13 percent intraday on Wednesday as the company received the US drug regulator's nod for a drug.

ANI Jan 18, 2017 16:39 IST googleads

Panacea Biotec up 13 pct on US FDA nod for migraine drug
New Delhi [India], Jan 18 (ANI): Shares of Panacea Biotec zoomed over 13 percent intraday on Wednesday as the company received the US drug regulator's nod for a drug. The company announced receiving of its approval for Rizatripan Bonzoate tablet, which is used to treat symptoms due to migraine from the US Food and Drug Administration's (FDA). The stocks have seen a good upside, with an upward movement of over 16 percent in the last month. Late in December, the scrip had seen a 10 percent intraday jump on the back of a vaccine roll out which is used in primary immunization and as a booster dose against diphtheria, tetanus, among others. Shares of Panacea Biotec were quoting at Rs. 141.00, up Rs. 15.30, or 12.17 percent, on the BSE. It touched an intraday high of Rs. 143.60 and an intraday low of Rs. 134.20. (ANI)

Get the App

What to Read Next

Business

Semicon Day 1: Rs 1 lakh crore investment commitments, 16 MoUs

Semicon Day 1: Rs 1 lakh crore investment commitments, 16 MoUs

The first day of SEMICON India 2026 saw the government lay out a wider roadmap for the next phase of India's semiconductor programme, with around Rs 1 lakh crore in investment commitments, plans to create close to one lakh jobs and a series of agreements spanning chip manufacturing, materials, packaging, design and talent development.

Read More
Business

No external pressure over MDR decision: DFS

No external pressure over MDR decision: DFS

"The allegation that MDR has been introduced under any external influence is patently false and misleading," the Department said

Read More
Business

India semiconductor push entering commercial production phase,

India semiconductor push entering commercial production phase,

India’s semiconductor push is beginning to move into a commercial production phase, with companies expanding local manufacturing, bringing products to market and building domestic supplier networks, according to industry executives at SEMICON India 2026.

Read More
Business

Tata Trusts asks Tata Sons to explore options other than listing

Tata Trusts asks Tata Sons to explore options other than listing

Tata Trusts on Thursday asked Tata Sons to explore all available options other than listing, reiterating their opposition to the public listing of the holding company and stressing the need to preserve the structure of the Tata Group.

Read More
Business

US jobless claims fall to 196,000, lowest since mid-July

US jobless claims fall to 196,000, lowest since mid-July

Initial jobless claims in the United States fell to 196,000 in the week ended September 12, their lowest level since mid-July, according to data released by the US Department of Labor on Thursday, a day after the Federal Reserve raised interest rates by 25 basis points.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.